Thrivent Financial for Lutherans
SCMP

Thrivent Financial for Lutherans’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Thrivent Financial for Lutherans’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,659
Closed -$281K – 2063
2017
Q4 		$281K Buy
15,659
+309
+2% +$3.8K ﹤0.01% 1910
2017
Q3 		$181K Buy
15,350
+80
+0.5% +$897 ﹤0.01% 1892
2017
Q2 		$160K Buy
15,270
+1,550
+11% +$15.8K ﹤0.01% 1874
2017
Q1 		$151K Buy
+13,720
New +$159K ﹤0.01% 1848

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Thrivent Financial for Lutherans's SCMP Position: Q1 2018 in Review

Thrivent Financial for Lutherans sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 15,659 shares — an estimated $281K sold.

Thrivent Financial for Lutherans first reported a position in SCMP in Q1 2017 and held it in 4 quarters. The position peaked at $281K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Thrivent Financial for Lutherans reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 15,659 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $281K.
  • Thrivent Financial for Lutherans first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2017 and held it in 4 quarters.
  • Thrivent Financial for Lutherans's Sucampo Pharmaceuticals, Inc. position peaked at $281K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2018, filed 8 May 2018.